These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocaña A, Stewart AF. J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445 [Abstract] [Full Text] [Related]
6. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism. Mallette LE, Kirkland JL, Gagel RF, Law WM, Heath H. J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629 [Abstract] [Full Text] [Related]
8. [Difference in the therapeutic response to active vitamin D3 between PTH-deficient hypoparathyroidism and pseudohypoparathyroidism]. Inoue D. Clin Calcium; 2007 Aug; 17(8):1255-61. PubMed ID: 17660624 [Abstract] [Full Text] [Related]
9. Studies on the attainment of normocalcemia in patients with pseudohypoparathyroidism. Breslau NA, Notman DD, Canterbury JM, Moses AM. Am J Med; 1980 Jun; 68(6):856-60. PubMed ID: 6247909 [Abstract] [Full Text] [Related]
17. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism. Aksnes L, Aarskog D. J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001 [Abstract] [Full Text] [Related]